Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “General Disorders and Administration Site Conditions”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT02174042
What this trial is testing

The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

Who this might be right for
General Disorders and Administration Site Conditions
Guizhou Bailing Group Pharmaceutical Co Ltd 120
Large-scale testing (Phase 3)Looking for participantsNCT07100730
What this trial is testing

Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Neoplastic DiseaseGlioblastomaGlioblastoma (GBM)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 50
Not applicableStudy completedNCT06118125
What this trial is testing

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Who this might be right for
Neoplasms, ColorectalGeneral PractitionerPandemic, COVID-19+4 more
University of Bordeaux 376
Large-scale testing (Phase 3)Looking for participantsNCT07221253
What this trial is testing

Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 1,100
Not applicableLooking for participantsNCT07411963
What this trial is testing

Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis

Who this might be right for
Myasthenia Gravis
Centre Hospitalier Universitaire de Nice 30
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Post-approval studies (Phase 4)UnknownNCT03811509
What this trial is testing

Breast Cancer Women on Aromatase Inhibitors Treatment

Who this might be right for
OsteoporosisOsteoporosis FractureArthralgia Generalized
Parc de Salut Mar 1,000
Not applicableStudy completedNCT02749110
What this trial is testing

Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner

Who this might be right for
Malignant Tumor of CervixCervical Intraepithelial Neoplasia
University Hospital, Lille 308
Not applicableEnded earlyNCT03843073
What this trial is testing

Connected Catheter- Safety and Effectiveness Study

Who this might be right for
Urinary RetentionNeurogenic BladderUrologic Diseases
Spinal Singularity 9
Not applicableNot Yet RecruitingNCT07170631
What this trial is testing

Effectiveness of a Therapeutic Exercise Program With Specific Upper Limb Exercises to Reduce Lymphedema and Neuropathy in Breast Cancer Patients: A Pre-post Study (LYNMA)

Who this might be right for
Lymphedema ArmLymphedema Due to RadiationLymphedema, Breast Cancer+2 more
Universitat Internacional de Catalunya 30
Testing effectiveness (Phase 2)Study completedNCT02087423
What this trial is testing

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 446
Not applicableLooking for participantsNCT07761026
What this trial is testing

AXIS MG Patient Registry

Who this might be right for
Myasthenia Gravis (MG)Myasthenia Gravis, GeneralizedMyasthenia Gravis, Ocular+12 more
Autoimmune Neurology Alliance 1,000
Not applicableLooking for participantsNCT02222844
What this trial is testing

Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers

Who this might be right for
CancerColorectal NeoplasmsColon, Sigmoid+2 more
Imperial College London 244
Not applicableStudy completedNCT04350398
What this trial is testing

Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer

Who this might be right for
Breast Cancer FemaleSide EffectsPsychological Distress+1 more
Alliance Equiphoria 83
Testing effectiveness (Phase 2)Study completedNCT04108026
What this trial is testing

Immunotherapy in Patient With Poor General Condition

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Intergroupe Francophone de Cancerologie Thoracique 50
Not applicableLooking for participantsNCT07247279
What this trial is testing

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Who this might be right for
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
AstraZeneca 450
Testing effectiveness (Phase 2)Study completedNCT02207530
What this trial is testing

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 112
Not applicableStudy completedNCT01407770
What this trial is testing

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Who this might be right for
Breast CancerCognitive Ability, GeneralFatigue+4 more
Wake Forest University Health Sciences 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06119581
What this trial is testing

First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Eli Lilly and Company 1,264
Large-scale testing (Phase 3)Study completedNCT03430843
What this trial is testing

Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 512
Next Page